Heydt C - Search Results

1

Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.

Riedel R, Fassunke J, Tumbrink HL, Scheel AH, Heydt C, Hieggelke L, Scheffler M, Heimsoeth A, Nogova L, Michels S, Weber JP, Fischer RN, Eisert A, Westphal T, Schaufler D, Siemanowski J, Ihle MA, Wagener-Ryczek S, Castiglione R, Pappesch R, Rehker J, Jürgens J, Stoelben E, Bunck A, Kobe C, Merkelbach-Bruse S, Sos ML, Büttner R, Wolf J. Riedel R, et al. Among authors: heydt c. Eur J Cancer. 2023 Jan;179:124-135. doi: 10.1016/j.ejca.2022.11.010. Epub 2022 Nov 15. Eur J Cancer. 2023. PMID: 36521334

2

Genetic basis of a solitary familial plexiform neurofibroma without verified associated neurofibromatosis.

Jungmann J, Heydt C, Bohle R, Pföhler C, Vogt T, Müller CS. Jungmann J, et al. Among authors: heydt c. J Dtsch Dermatol Ges. 2016 May;14(5):525-7. doi: 10.1111/ddg.12990. J Dtsch Dermatol Ges. 2016. PMID: 27119482 No abstract available.

3

Genetische Grundlagen eines solitären familiären plexiformen Neurofibroms ohne verifizierte begleitende Neurofibromatose.

Jungmann J, Heydt C, Bohle R, Pföhler C, Vogt T, Müller CS. Jungmann J, et al. Among authors: heydt c. J Dtsch Dermatol Ges. 2016 May;14(5):525-8. doi: 10.1111/ddg.12990_g. J Dtsch Dermatol Ges. 2016. PMID: 27119483 No abstract available.

4

[Current challenges in pathology - practical solutions for commonly occurring problems: Introduction to the 49th symposium of the German division of the International Academy of Pathology, 22-24 February 2013, in Bonn].

Heydt C, Büttner R. Heydt C, et al. Pathologe. 2013 Feb;34(1):8. doi: 10.1007/s00292-012-1701-x. Pathologe. 2013. PMID: 23299984 German. No abstract available.

5

Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnostics.

Heydt C, Fassunke J, Künstlinger H, Ihle MA, König K, Heukamp LC, Schildhaus HU, Odenthal M, Büttner R, Merkelbach-Bruse S. Heydt C, et al. PLoS One. 2014 Aug 8;9(8):e104566. doi: 10.1371/journal.pone.0104566. eCollection 2014. PLoS One. 2014. PMID: 25105902 Free PMC article.

6

PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies.

Scheffler M, Bos M, Gardizi M, König K, Michels S, Fassunke J, Heydt C, Künstlinger H, Ihle M, Ueckeroth F, Albus K, Serke M, Gerigk U, Schulte W, Töpelt K, Nogova L, Zander T, Engel-Riedel W, Stoelben E, Ko YD, Randerath W, Kaminsky B, Panse J, Becker C, Hellmich M, Merkelbach-Bruse S, Heukamp LC, Büttner R, Wolf J. Scheffler M, et al. Among authors: heydt c. Oncotarget. 2015 Jan 20;6(2):1315-26. doi: 10.18632/oncotarget.2834. Oncotarget. 2015. PMID: 25473901 Free PMC article.

7

MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.

Schmitz K, Koeppen H, Binot E, Fassunke J, Künstlinger H, Ihle MA, Heydt C, Wardelmann E, Büttner R, Merkelbach-Bruse S, Rüschoff J, Schildhaus HU. Schmitz K, et al. Among authors: heydt c. PLoS One. 2015 Apr 6;10(4):e0120079. doi: 10.1371/journal.pone.0120079. eCollection 2015. PLoS One. 2015. PMID: 25844809 Free PMC article.

8

Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy.

Heydt C, Kumm N, Fassunke J, Künstlinger H, Ihle MA, Scheel A, Schildhaus HU, Haller F, Büttner R, Odenthal M, Wardelmann E, Merkelbach-Bruse S. Heydt C, et al. BMC Cancer. 2015 Apr 15;15:291. doi: 10.1186/s12885-015-1311-0. BMC Cancer. 2015. PMID: 25886408 Free PMC article.

9

miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.

Ihle MA, Trautmann M, Kuenstlinger H, Huss S, Heydt C, Fassunke J, Wardelmann E, Bauer S, Schildhaus HU, Buettner R, Merkelbach-Bruse S. Ihle MA, et al. Among authors: heydt c. Mol Oncol. 2015 Aug;9(7):1421-33. doi: 10.1016/j.molonc.2015.03.013. Epub 2015 Apr 10. Mol Oncol. 2015. PMID: 25898773 Free PMC article.

10

FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro.

Künstlinger H, Fassunke J, Schildhaus HU, Brors B, Heydt C, Ihle MA, Mechtersheimer G, Wardelmann E, Büttner R, Merkelbach-Bruse S. Künstlinger H, et al. Among authors: heydt c. Oncotarget. 2015 Aug 21;6(24):20215-30. doi: 10.18632/oncotarget.4046. Oncotarget. 2015. PMID: 26036639 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page